
In a new study, Northwestern University and Shirley Ryan AbilityLab researchers have discovered that, in an attempt to adapt to this impairment, muscles actually lose sarcomeres — their smallest, most basic building blocks.

Inhibiting a specific protein complex in SARS-CoV-2, the virus that causes COVID-19, may be a promising therapeutic target for treating the disease, according to a Northwestern Medicine study.

A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study.

One of the biggest diseases of the modern era is a pernicious cluster of risk factors called metabolic syndrome, and Northwestern scientists across disciplines are looking for new ways to understand, target, treat, and even prevent this syndrome, with the hopes of ultimately creating a much healthier nation.

Northwestern Medicine investigators continue to assess COVID-19 treatments for mild to severe cases, the widespread adoption of telemedicine, and why a “return to normal” will be a missed opportunity to improve healthcare.

For the first time, scientists have examined how the three-dimensional structure of chromatin can play a part in the development of bladder cancer and pediatric brain tumors, according to a pair of Northwestern Medicine studies.

Pregnant women who are diagnosed with COVID-19 have a higher risk of severe maternal morbidity and mortality and neonatal complications compared to pregnant women without COVID-19, according to recent findings.

The failure of epithelial cells to complete a stem cell-like transition may lead to pulmonary fibrosis, according to a Northwestern Medicine study.

Northwestern Medicine scientists and clinicians have continued to investigate methods to combat the disease, including strategies to conduct clinical trials during a pandemic, studying neurologic symptoms in children and reflecting on the importance of professional medical organizations during a public health crisis.

Alterations in the balance of two chloride transporters may be responsible for cognitive deficits in schizophrenia, according to a Northwestern Medicine study.
Notifications